MINAPHARM Pharmaceuticals reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was EGP 984.64 million compared to EGP 754.82 million a year ago. Net income was EGP 184 million compared to EGP 102.01 million a year ago. Basic earnings per share from continuing operations was EGP 17.41 compared to EGP 8.4 a year ago.
For the nine months, sales was EGP 2,645.19 million compared to EGP 2,208.9 million a year ago. Net income was EGP 448.81 million compared to EGP 352.37 million a year ago.